Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No. I think they are in deep doo doo. They just held their Q3 conference call, and took ZERO questions. What's that about? I think that level of silence speaks volumes. It looks like they are burning more than $10m of cash a quarter, with only $30m of cash remaining - but it's really only $20m if you net out the $10m of cash borrowed from Silicon Valley Bank term loan during the quarter. The working capital #'s are starting to look a bit strange: sales down, and A/R down commensurately, BUT Inventories UP, and A/P UP! It sure looks like they are stretching their payables. Who wants to do the A/P days calculation? Who wants to read the SVB loan agreement to see if covenants were tripped, or will be shortly?
On 7/27/21 Bloomberg reported that FLDM was working with an advisor and speaking to potential buyers of the company. That was 3 months ago, and: nothing. So today they announce a "Strategic Review . . . to maximize shareholder value". This looks like the trajectory of a distressed company, doesn't it?
06:28
$FLDM
Fluidigm: Trump Administration provides saliva test at surge testing site in Waco, TX (6.75)
"Starting today, communities that are part of the federal surge testing effort for COVID-19, supported by the Trump Administration, have a new option: a test that uses samples of saliva collected by spitting into a sterile container. Made by Fluidigm Corporation and supported in part by the National Institutes of Health (NIH), the easy-to-use saliva test detects SARS-CoV-2, the virus that causes COVID-19, on a molecular level using a microfluidics platform. The accuracy of the test is comparable to other molecular-level tests of nasal swab samples, according to a clinical study conducted by the manufacturer. The U.S. Department of Health and Human Services (HHS) has traditionally provided nasal swab tests from other manufacturers to surge testing sites, which remain a choice for community officials."
https://www.hhs.gov/about/news/2020/10/16/trump-administration-provides-saliva-test-at-surge-testing-site-in-waco-tx.html
Don’t want to jinx it, but currently the stock is up 90%. Hope that means we’ll see a big gap opening tomorrow.
Does anybody know, when they are expecting the NHI approval and what is still open regarding the approval?
The retarded Newscum of Khalifhurnia should do the same..
Patience is the key here..
Fluidigm Corporation (Nasdaq: $FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Company’s Rapid Acceleration of Diagnostics (RADx) project.
https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83214731/fluidigm-achieves-initial-milestone-under-nih-rapi
8K Item 8.01. Other Events.
From August 13, 2020 through September 3, 2020, Fluidigm Corporation (the “Company”) sold a total of 2,479,517 shares of its common stock for aggregate gross proceeds of approximately $20.9 million before commissions and offering expenses under its previously announced “at-the-market” equity offering program. The sales were completed pursuant to the Open Market Sale AgreementSM with Jefferies LLC dated as of March 4, 2020, which the Company filed as an exhibit to a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 5, 2020.
https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83213327/current-report-filing-8-k
The Law Offices of Frank R. Cruz Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors $FLDM https://newsfilter.io/a/0a76fc698a3e38b64c511d5e5683326e
$FLDM should have a good bounce
$FLDM Gov of Missouri is working in the "coming weeks" to roll out the saliva based test to all Missouri citizens
$FLDM Governor to talk saliva-based COVID-19 test https://www.newspressnow.com/news/regional_news/central_missouri/governor-to-talk-saliva-based-covid-19-test/article_aa493c13-9d63-561b-a78c-e66218ec79e4.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via @newspressnow
Quick testing is still highly demanded. Especially with schools starting now.
Not sure it might be over it’s all about the cure now
Agree. That’s why I’m saying it’s going up from here.
This entire sector has been down
OPK as well
You here for short gains? That streak would be over now ;)
LOL counting those chickens I see
But it’s red LOL
Today is the turnaround. First Green Day in a week. Up from here.
They’ll have to bring out news soon. Implementation in colleges and schools would be the perfect news.
NIH grant monies and full approval coming next i think- also usage data will hopefully show detection earlier than other tests and greater accuracy $FLDM
It’ll jump next week again, if they bring out an official statement.
$FLDM
ECHO performer, @fluidigm, has been awarded Emergency Use Authorization (EUA) by the FDA for their saliva-based COVID-19 test. Their microfluidics platform, developed with support from DARPA, has a capacity to conduct up to 6,000 tests per day per system. https://t.co/rE5iNK57wU pic.twitter.com/spb2TvJYDO
— DARPA (@DARPA) August 28, 2020
$FLDM Interview on Washington University's new Saliva COVID test
Rich Head, MS, Director, Genome Technology Access Center,
@GenomeInstitute
, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.
Rich Head, MS, Director, Genome Technology Access Center, @GenomeInstitute, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.https://t.co/XEfuhGUsIf
— Standard BioTools (@Standard_BioT) August 29, 2020
Where did you see that?
Sounds good to me..
Fluidigm $FLDM Price Target Raised to $16.00 at UBS Group
Hoping for a good post market move, so we can see some additional gain tomorrow.
Never stop learning lessons. Priceless.
I rarely pick it right either, but this was pretty obvious. Thx for the kudos ;)
Great call. Wish I had the knowledge to be able to see these things. Thanks
Accuracy of that test is questionable. But BP can get away with it. Rigged system. Money talks and FDA listens.
WHOA! my $7.65 buys this morning starts to look good..
$20 or better by end of year..
That was a fleeting moment of hype, now a new test is approved that costs $5 and takes 5 minutes for results.
I'm at an avg. of $9.41 and feel good about it.
Thinking anything under $10.00 is a REALLY GREAT investment here. BWDIK lol
Bittersweet, I was fine with 1000 shares at 10.
I guess 3200 is what it needed.
Try to get my shares NOW... LOL
It’ll bottom at 7.50. Then go back to around 9 in the afternoon.
Abbott tests highly inaccurate.
Is this worth getting into? Looks like it took a fall at the opening..
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
599
|
Created
|
05/01/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |